Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 11/20 | 0.41 |
| ▸ | GAA | P10253 | 7/20 | 0.40 |
| ▸ | MAPT | P10636 | 7/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | SNCA | P37840 | 4/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22080501 | 1.00 | NOX1 (0.41) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL21078425 | 0.94 | SNCA (0.33) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL21078393 | 0.76 | NOX1 (0.45) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL18364941 | 0.76 | NOX1 (0.48) | NOX1GAAMAPTMEN1KMT2A | |
| Phenothiazine SCHEMBL28781231 | 0.73 | NOX1 (0.71) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL223661 | 0.72 | NOX1 (0.50) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL8150371 | 0.72 | NOX1 (0.50) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL8156091 | 0.72 | NOX1 (0.50) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL2211988 | 0.71 | NOX1 (0.37) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL8156018 | 0.69 | NOX1 (0.62) | NOX1GAAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190169519-A1 | MULTIFUNCTIONAL LUBRICATING OIL BASE STOCKS AND PROCESSES FOR PREPARING SAME | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169519-A1 | MULTIFUNCTIONAL LUBRICATING OIL BASE STOCKS AND PROCESSES FOR PREPARING SAME | DEGS1, SAMM50, F12 | NOX1 524/4885GAA 4540/4885MAPT 3565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.